UK MHRA completes inspection of Wockhardt’s Chikalthana plant

30 Sep 2016 Evaluate

UK health regulator -- UK Medicines and Healthcare Products Regulatory Agency (MHRA) -- has completed inspection of Wockhardt’s Chikalthana plant at Aurangabad in Maharashtra without making any critical observations.

The inspection of the company’s manufacturing unit at L-1, Chikalthana, Aurangabad in Maharashtra by UK MHRA has since been completed without any critical observations and the approval status of the said unit continues.

In December 2015, Wockhardt had received a good manufacturing practice (GMP) certificate from the UK health regulator for its Chikalthana plant after an inspection.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1176.90 -9.75 (-0.82%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×